Table 3.
Length of hospital stay.
| LOSa |
p-value b | ||
|---|---|---|---|
| Mean ± SD | Median (range) | ||
| Male (n = 306) | 12 ± 11 | 9 (5—107) | 0.14 |
| Female (n = 66) | 14 ± 11 | 9 (4—60) | |
| Age < 65 years (n = 193) | 11 ± 8 | 8 (4—60) | 0.02 * |
| Age ≥ 65 years (n = 179) | 14 ± 14 | 9 (5—107) | |
| Alternative pathway group (n = 105) | 10 ± 8 | 7 (5—54) | <0.001 * |
| Conventional pathway group (n = 267) | 13 ± 12 | 9 (4—107) | |
| No comorbidity (n = 53) | 10 ± 5 | 8 (5—34) | 0.16 |
| Any comorbidity (n = 319) | 13 ± 12 | 9 (4—107) | |
| No CV disease (n = 262) | 11 ± 9 | 8 (4—60) | 0.009 * |
| CV disease (n = 110) | 15 ± 15 | 9 (5—107) | |
| No COPD (n = 349) | 12 ± 11 | 8 (4—107) | 0.03 * |
| COPD (n = 23) | 17 ± 16 | 11 (5—73) | |
| No neoadj. therapy (n = 154) | 13 ± 12 | 9 (5—107) | 0.09 |
| Neoadj. therapy (n = 218) | 12 ± 11 | 8 (4—73) | |
| Type of oesophagectomy | |||
| Trans-hiatal (n = 110) | 13 ± 13 | 8 (4—107) | 0.13 |
| McKeown (n = 30) | 16 ± 16 | 11 (5—65) | |
| Ivor Lewis (n = 232) | 12 ± 10 | 8 (5—73) | |
CV disease: cardiovascular disease.
a
Intra-hospital deaths excluded.
b
Significance tested using Mann—Whitney test
*
p < 0.05.